Clinical Impact of RANK Signalling in Ovarian Cancer

Ovarian cancer (OC) is a gynaecological malignancy with poor clinical outcome and limited treatment options. The receptor activator of nuclear factor-κB (RANK) pathway, activated by RANK ligand (RANKL), critically controls bone metabolism, tumourigenesis and tumour immune responses. Denosumab, a mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Wieser, Verena, Sprung, Susanne, Tsibulak, Irina, Haybaeck, Johannes, Hackl, Hubert, Fiegl, Heidelinde, Marth, Christian, Zeimet, Alain Gustave
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627676/
https://www.ncbi.nlm.nih.gov/pubmed/31181781
http://dx.doi.org/10.3390/cancers11060791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627676/
https://www.ncbi.nlm.nih.gov/pubmed/31181781
http://dx.doi.org/10.3390/cancers11060791

Ejemplares similares